Avoca signs astaxanthin agreement with Synthetic Genomics
date:Jun 25, 2014
is an ideal agreement for both companies. Commercialization of astaxanthin with Avoca demonstrates how we can supply important high quality, natural ingredients to the market using our algae technology.

Natural astaxanthin is a supplement claimed to have multiple clinically-proven health benefits associated with its powerful antioxidant and anti-inflammatory properties. Natural astaxanthin is, according to SGI, very difficult to produce and therefore is supply constrained relative to demand. SG
4/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/08 18:27